Glycobiology of neuromuscular disorders

Glycobiology

Volumn 13, Issue 8, 2003, Pages

  Martin, Paul T ^a   Freeze, Hudson H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Congenital disorders of glycosylation; Dystroglycan; Laminin; Muscular dystrophy; Skeletal muscle

Indexed keywords

DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; HYBRID PROTEIN;

CARBOHYDRATE METABOLISM; CYTOTOXIC T LYMPHOCYTE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; INCLUSION BODY MYOSITIS; MUSCULAR DYSTROPHY; NEUROMUSCULAR DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; REVIEW;

ANIMALS; CYTOSKELETAL PROTEINS; GLYCOPROTEINS; HUMANS; INCLUSION BODIES; MUSCULAR DYSTROPHIES; N-ACETYLNEURAMINIC ACID; NEUROMUSCULAR DISEASES;

EID: 0042196026     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/cwg077     Document Type: Review

References (60)

1. Aravind, L. and Koonin, E.V. (1999) The fukutin protein family-predicted enzymes modifying cell-surface molecules. Curr. Biol., 9, R836-R837.
2. Askanas, V. and Engel, W.K. (2001) Inclusion body myositis: newest concepts of pathogenesis and relation to aging and Alzhemier disease. J. Neuropathol. Exp. Neurol., 60, 1-14.
3. Beltran-Valero de Bernabe, D., Currier, S., Steinbrecher, A., Celli, J., Beusekom, E., van er zwaag, B., Kayserili, H., Merlini, L., Chitayat, D., Dobyns, W.B., and others. (2002) Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J. Hum. Genet., 71, 2002.
4. Bennet, E., Urcan, M.S., Tinkle, S.S., Koszowski, A.G., and Levinson, S.R. (1997) Contribution of sialic acid to the voltage dependence of sodium channel gating. A possible electrostatic mechanism. J. Gen. Physiol., 109, 327-343.
5. Brockington, M., Blake, D.J., Prandini, P., Brown, S.C., Torelli, S., Benson, M.A., Ponting, C.P., Estournet, B., Romero, N.B., Mercuri, E., and others. (2001a) Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α dystroglycan. Am J. Hum. Genet., 69, 1198-1209.
6. Brockington, M., Yuva, Y., Prandinin, P., Torelli, S., Benson, M.A., Hermann, R., Anderson, L.V., Bashir, R., Burgunder, J.M., Fallet, S., and others. (2001b) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congential muscular dystrophy MDC1C. Human Mol. Genet., 10, 2851-2859.
7. Burkin, D.J., Wallace, G.Q., Nicol, K.J., Kaufman, D.J., and Kaumfan, S.J. (2001) Enhanced expression of the α7β1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J. Cell Biol., 152, 1207-1218.
8. Chai, W., Yuen, C-T., Kogelberg, H., Carruthers, R.A., Margolis, R.U., Feizi, T., and Lawson, A.M. (1999) High prevalence of 2-mono and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. Eur. J. Biochem., 263, 879-888.
9. Chou, H.H., Takematsu, H., Diaz, S., Iber, J., Nickerson, E., Wright, K.L., Muchmore, E.A., Nelson, D.L., Warren, S.T., and Varki, A. (1998) A mutation in the human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc. Natl Acad. Sci. USA, 95, 11751-11756.
10. Cohn, R., Henry, M., Michele, D., Barresi, R., Saito, F., Moore, S., Flanagan, J., Skwarchuk, M., Robbins, M., Mendell, J., and others. (2002) Disruption of dag1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell, 110, 639-648.
11. Cormand, B., Pihko, H., Bayes, M., Valanne, L., Santavouri, P., Talim, B., Gerhsoni-Baruch, R., Ahmand, A., van Bokhoven, H., Brunner, H.G., and others. (2001) Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology, 56, 1059-1069.
12. Deconinck, N., Tinsley, J., De Backer, F., Fisher, R., Kahn, D., Phelps, S., Davies, K., and Gillis, J-M. (1997) Expression of a truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nature Med., 3, 1216-1221.
13. Effertz, K., Hinderlich, S., and Ruetter, W. (1999) Selective loss of either the epimerase or kinase activity of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase due to site-directed mutagenesis based on sequence alignments. J. Biol. Chem., 274, 28771-28778.
14. Eisenberg, I., Avidan, N., Potikha, T., Hochner, H., Chen, M., Olender, T., Barash, M., Shemesh, M., Sadeh, M., Grabov-Nardini, G., and others. (2001) The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nature Genet., 29, 83-87.
15. Esapa, C.T., Benson, M.A., Schroder, J.E., Martin-Rendon, E., Brockington, M., Brown, S.C., Mutoni, F., Kroger, S., and Blake, D.J. (2002) Functional requirements for fukutin-related protein in the Golgi apparatus. Hum. Mol. Genet., 11, 3319-3331.
16. Fermini, B. and Nathan, R.D. (1991) Removal of sialic acid alters both T- and L-type calcium currents in cardiac myocytes. Am. J. Physiol., 260, H735-H743.
17. Freeze, H.H. (2001) Update and perspectives on congenital disorders of glycosylation. Glycobiology, 11, 129R-143R.
18. Fukuda, S., Sumii, M., Masuda, Y., Takahashi, M., Koike, N., Teishima, J., Yasumoto, H., Itamoto, T., Ashara, T., Dohi, K, and Kamiya, K. (2001) Murine and human SDFL1 is an endoplasmic reticulum stress-inducible gene and encodes a new member of the Pmt/rt protein family. Biochem. Biophys. Res. Commun., 280, 407-414.
19. Fukuyama, Y., Osawa, M., and Suzuki, H. (1984) Congenital muscular dystrophy of the Fukuyama type-clinical, genetic, and pathological considerations. Brain Dev., 3, 1-30.
20. Grewal, P.K., Holzfeind, P.J., Bittner, R.E., and Hewitt, J.E. (2001) Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nature Genet., 28, 151-154.
21. Hamada, T., Tashiro, K., Tada,, H., Inazawa, J., Shirozu, M., Shibahara, K., Nakamura, T., Martina, N., Nakano, T., and Honjo, T. (1996) Isolation and characterization of a novel secretory protein, stromal cell-derived factor-2 (SDF-2), using signal sequence trap method. Gene, 176, 211-214.
22. Hayashi, Y.K., Ogawa, M., Tagawa, K., Noguchi, S., Ishihara, T., Nonaka, I., and Arahata, K. (2001) Selective deficiency of alpha dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology, 57, 115-121.
23. Heinrichs, D.E., Yethon, J.A., and Whitfield, C. (1998) Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol. Microbiol., 30, 221-232.
24. Hinderlich, S., Stache, R., Zeitler, R., and Reutter, W. (1997) A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis in rat liver: Purification and characterization of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. J. Biol. Chem., 272, 24313-24318.
25. Hinderlich, S., Berger, M., Keppler, O.T., Pawlita, M., and Reutter, W. (2001) Biosynthesis of N-acetylneuraminic acid in cells lacking UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. Biol. Chem., 283, 291-297.
26. Hinderlich, S., Eisenberg, I., Horstkorte, R., Reutter, W., and Mitrani-Rosenbaum, S. (2002) Is hereditary inclusion body myopathy a glycosylation disease? Glycobiology, 12, 643.
27. Holzfeind, P.J., Grewal, P.K., Reitsamer, H.A., Kechvar, J., Lassmann, H., Hoeger, H., Hewitt, J.E., and Bittner, R.E. (2002) Skeletal, cardiac, and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the LARGEmyd mouse defines a natural model for glycosylation-dependent muscle-eye-brain disorders. Hum. Mol. Genet., 11, 2673-2687.
28. Huizing, M., Hermos, C.R., Vasconselos, O.M., Orvisky, E., Krasnewich, D., Dalakas, D., and Gahl, W.A. (2002) Hereditary inclusion body myopathy due to mutations in the gene for UDP-GlcNAc 2-epimerase/ManNAc kinase. Am. J. Hum. Genet., 173, 71.
29. Izumi, T., Hara, K., Ogawa, T., Osawa, M., Saito, K., Novo, M.L., Fukuyama, Y., and Takashima, S. (1995) Abnormality of cerebral gangliosides in Fukuyama type congenital muscular dystrophy. Brain Dev., 17, 33-37.
30. Jurado, L.A., Coloma, A., and Cruces, J. (1999) Identification of a human homologue of the Drosophila rotated abdomen gene (POMT1) encoding a putative protein O-mannosyl-transferase, an assignment to human chromosome 9q34.1. Genomics, 58, 171-180.
31. Kano, H., Kobayashi, K., Herrmann, R., Tachikawa, M., Manya, H., Nishino, I., Nonaka, I., Straub, V., Talim, B., Voit, T., and others. (2002) Deficiency of alpha dystroglycan in muscle-eye brain disease. Biochem. Biophys. Res. Commun., 291, 1283-1286.
32. Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M., and others. (1998) An ancient retrotransposonal insertion causes Fukuyama-type congenital muscular dystrophy. Nature, 394, 388-392.
33. Lane, P.W., Beamer, T.C., and Myers, D.D. (1976) Myodystrophy, a new myopathy on chromosome 8 of the mouse. J. Hered., 67, 135-138.
34. Marquardt, T., Luhn, K., Srikrishna, G., Freeze, H.H., Harms, E., and Vestweber, D. (1999) Correction of leukocyte adhesion deficiency type II with oral fucose. Blood, 94, 3976-3985.
35. Martin, P.T., Scott, L.J.C., Porter, B.E., and Sanes, J.R. (1999) Distinct structures and functions of related pre- and postsynaptic carbohydrates at the mammalian neuromuscular junction. Mol. Cell. Neurosci., 13, 105-118.
36. Mathews, K.D., Rapisarda, D., Bailey, H.L., Murray, J.C., Schleper, R.L., and Smith, R. (1995) Phenotypic and pathological evaluation of the myd mouse. A candidate model for facioscapulohumeral dystrophy. J. Neuropathol. Exp. Neurol., 54, 601-606.
37. Matsumura, K., Ervasti, J.M., Ohlendieck, K., Kahl, S.D., and Campbell, K.P. (1992) Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature, 360, 588-591.
38. Messner, D.J. and Catterall, W.A. (1985) The sodium channel from rat brain. J. Biol. Chem., 260, 10597-10604.
39. Michele, D.E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R.D., Satz, J.S., Dollar, J., Nishino, I., Kelley, R.I., Somer, H., and others. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature, 418, 417-422.
40. Moll, J., Barzaghi, P., Lin, S., Bezakova, G., Lochmuller, H., Engvall, E., Muller, U., and Ruegg, M.A. (2001) An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature, 413, 302-307.
41. Moore, S.A., Saito, F., Chen, J., Michele, D.E., Henry, M.D., Messing, A., Cohn, R.D., Ross-Barta, S.E., Westra, S., Williamson, R.A., and others. (2002) Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature, 418, 422-425.
42. Muthing, J., Maurer, U., Weber-Schurholz, S. (1998) Glycosphingolipids of skeletal muscle: II. Modulation of Ca2+-flux in triad membanes by gangliosides. Carbohydr. Res., 307, 147-157.
43. Nguyen, H.H., Jayasinha, V., Xia, B., Hoyte, K., and Martin, P.T. (2002) Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Proc. Natl Acad. Sci. USA, 99, 5616-5621.
44. Oetke, C., Hinderlich, S., Brossmer, R., Reutter, W., Pawlita, M., and Keppler, O.T. (2001) Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells. Eur. J. Biochem., 268, 4553-4561.
45. Oldfors, A. and Lindberg, C. (1999) Inclusion body myositis. Curr. Opin. Neurol., 12, 527-533.
46. Patton, B.L., Connolly, A.M., Martin, P.T., Cunningham, J.M., Mehta, S., Pestronk, A., Miner, J.H., and Sanes, J.R. (1999) Distribution of ten laminin chains in dystrophic and regenerating muscles. Neuromusc. Dis., 9, 423-433.
47. Recio-Pinto, E., Thornhill, W.B., Duch, D.S., Levinson, S.R., and Urban, B.W. (1990) Neuraminidase treatment modifies the function of electroplax sodium channels in planar lipid bilayers. Neuron, 5, 675-684.
48. Sanes, J.R. and Cheney, J.M., (1982) Lectin binding reveals a synapse-specific carbohydrate in skeletal muscle. Nature, 300, 646-647.
49. Sasaki, K., Kurata-Miura, K., Ujita, M., Angata, K., Nakagawa, S., Sekine, S., Nishi, T., and Fukuda, M. (1997) Expression cloning of cDNA encoding a human beta-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis. Proc. Natl Acad. Sci. USA, 94, 14294-14299.
50. Schwarzkopf, M., Knobeloch, K.P., Rohde, E., Hinderlich, S., Wiechens, N., Lucka, L., Horak, I., Reutter, W., and Horstkorte, R. (2002) Sialylation is essential for early development. Proc. Natl Acad. Sci. USA, 99, 5267-5270.
51. Seppala, R., Lehto, V.P., and Gahl, W.A. (1999) Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialurea and the allosteric site of the enzyme. Am. J. Hum. Genet., 64, 1563-1569.
52. Smith, P.L. and Lowe, J.B. (1994) Molecular cloning of a murine N-acetylgalactosamine transferase cDNA that determines the expression of the T lymphocyte-specific CT oligosaccharide antigen. J. Biol. Chem., 269, 15162-15171.
53. Smith, P.L., Myers, J.T., Rogers, C.E., Zhou, L., Petryniak, B., Becker, D., Homeister, J.W., and Lowe, J.B. (2002) Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus. J. Cell Biol., 158, 801-815.
54. Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Sphelps, S., Gillis, J-M., and Davies, K. (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nature Med., 4, 1441-1444.
55. Varki, A. (2001) Loss of N-glycolylneuraminic acid in humans: mechanisms, consequences, and implications for hominid evolution. Yearbook Phys. Anthropol., 44, 54-69.
56. Wehling, M., Spencer, M.J., and Tidball, J.G. (2001) A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol., 155, 123-131.
57. Xia, B., Hoyte, K., Kammesheidt, A., Deerinck, T., Ellisman, M., and Martin, P.T. (2002) Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression. Dev. Biol., 242, 58-73.
58. Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M., and others. (2001) Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell, 1, 717-724.
59. Zhang, Y., Hartmann, H.A., and Satin, J. (1999) Glycosylation influences voltage-dependent gating of cardiac and skeletal muscle sodium channels. J. Mem. Biol., 171, 195-207.
60. Zhang, W., Betel, D., and Schachter, H. (2002) Cloning and expression of a novel UDP-GlcNAc:α-D-mannoside β1,2-N-acetyl-glucosaminyltransferase homologous to UDP-GlcNAc:α-3-D-mannoside β1,2-Nacetylglucosaminyltransferase I. Biochem. J., 361, 153-162.